• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Rep Med . Rewired type I IFN signaling is linked to age-dependent differences in COVID-19

tetano

Editor, Senior Moderator
Cell Rep Med


. 2025 Aug 19;6(8):102285.
doi: 10.1016/j.xcrm.2025.102285. Rewired type I IFN signaling is linked to age-dependent differences in COVID-19

Lev Petrov[SUP] 1 [/SUP], Sophia Brumhard[SUP] 1 [/SUP], Sebastian Wisniewski[SUP] 2 [/SUP], Philipp Georg[SUP] 1 [/SUP], David Hillus[SUP] 3 [/SUP], Anna Hiller[SUP] 1 [/SUP], Rosario Astaburuaga-García[SUP] 4 [/SUP], Nils Blüthgen[SUP] 4 [/SUP], Emanuel Wyler[SUP] 5 [/SUP], Katrin Vogt[SUP] 1 [/SUP], Hannah-Philine Dey[SUP] 1 [/SUP], Saskia von Stillfried[SUP] 6 [/SUP], Christina Iwert[SUP] 1 [/SUP], Roman D Bülow[SUP] 6 [/SUP], Bruno Märkl[SUP] 7 [/SUP], Lukas Maas[SUP] 1 [/SUP], Christine Langner[SUP] 8 [/SUP], Tim Meyer[SUP] 9 [/SUP], Jennifer Loske[SUP] 10 [/SUP], Roland Eils[SUP] 11 [/SUP], Irina Lehmann[SUP] 11 [/SUP], Benjamin Ondruschka[SUP] 12 [/SUP], Markus Ralser[SUP] 13 [/SUP], Jakob Trimpert[SUP] 8 [/SUP], Peter Boor[SUP] 14 [/SUP], Sammy Bedoui[SUP] 15 [/SUP], Christian Meisel[SUP] 9 [/SUP], Marcus A Mall[SUP] 16 [/SUP], Victor M Corman[SUP] 17 [/SUP], Leif Erik Sander[SUP] 1 [/SUP], Jobst Röhmel[SUP] 18 [/SUP], Birgit Sawitzki[SUP] 19 [/SUP]



Affiliations
Abstract

Advanced age is the most important risk factor for severe disease or death from COVID-19, but a thorough mechanistic understanding of the molecular and cellular underpinnings is lacking. Multi-omics analysis of 164 samples from SARS-CoV-2-infected persons aged 1 to 84 years reveals a rewiring of type I interferon (IFN) signaling with a gradual shift from signal transducer and activator of transcription 1 (STAT1) to STAT3 activation in monocytes, CD4[SUP]+[/SUP] T cells, and B cells with increasing age. Diversion of IFN signaling is associated with increased expression of inflammatory markers, enhanced release of inflammatory cytokines, and delayed contraction of infection-induced CD4[SUP]+[/SUP] T cells. A shift from IFN-responsive germinal center B (GCB) cells toward CD69[SUP]high[/SUP] GCB and atypical B cells during aging correlates with immunoglobulin (Ig)A production in children, whereas complement-fixing IgG predominates in adults. Our data provide a mechanistic basis for inflammation-prone responses to infections and associated pathology during aging.

Keywords: B cells; COVID-19; SARS-CoV-2; STAT1; STAT3; T cells; age; antibodies; children; immune response; monocytes; signaling; type I IFN.

 
Back
Top Bottom